Harvard Bioscience Sees Q2 Sales $18.000M-$20.000M vs $19.20M Est
Benzinga Newsdesk 1 year ago
NewsGuidance
Harvard Bioscience (NASDAQ:HBIO) sees Q2 sales of $18.000 million-$20.000 million vs $19.20 million analyst estimate.
Harvard Bioscience (NASDAQ:HBIO) sees Q2 sales of $18.000 million-$20.000 million vs $19.20 million analyst estimate.